Our data suggest that the CD163-positive embedded stromal cells likely have a role in sustaining the aggressiveness of cancer cells, but the presence of pro-tumor macrophages alone may not be sufficient to affect the outcome of TNBC patients. This evidence concerns the gene CD163 and neoplasm.